Compared to healthy controls, T cells in CLL patients have downregulated genes encompassing cell differentiation (CD4+), cytoskeleton formation, vesicle trafficking and cytotoxicity (CD8+). Here, CD4 is linked to B-cell chronic lymphocytic leukemia.